NHS South of England Branded Medicines - Tranche A - Contracts Finder Award Notice

NHS Framework for the NHS South of England, Branded Medicines - Tranche A, Cytokine Modulators and other monoclonal Antibodies, and Antiretrovirals (Doravirine only) for Midlands & East and North of England.

Offer reference number: CM/PHR/16/5521

CM/PHR/16/5521/01 - NHS Framework for the NHS South of England, Branded Medicines - Tranche A, Period of framework: 1 September 2019 to 31 August 2021 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

CM/PHR/16/5521/02 - NHS Framework for the NHS South of England, Branded Medicines - Annual Tranche - Cytokine Modulators and other monoclonal antibodies, Period of framework: 1 September 2019 to 31 August 2020 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 12 months

CM/PHR/16/5521/03 - NHS Framework Agreement for Proprietary Pharmaceuticals Interim 2019 - Midlands & East and North of England, Period of framework agreement: Midlands & East 1 September 2019 to 29 February 2020: North of England 1 September 2019 to 28 February 2021